US Patent 12012445 Anti-VEGF protein compositions and methods for producing the same

Is a

Patent

Patent attributes

Patent Applicant

Regeneron Pharmaceuticals

Current Assignee

Regeneron Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120124450

Patent Inventor Names

Shawn Lawrence0

Hunter Chen0

Ning Li0

Meghan Casey0

Amardeep Singh Bhupender Bhalla0

Jaimie Grapel0

Shunhai Wang0

Amy Johnson0

Date of Patent

June 18, 2024

Patent Application Number

182142820

Date Filed

June 26, 2023

Patent Citations

‌

US Patent 9670519 Methods for reducing accumulation of lactate during culturing and method for producing polypeptide

‌

US Patent 10017732 Cell culture compositions with antioxidants and methods for polypeptide production

‌

US Patent 10927342 Taurine supplemented cell culture medium and methods of use

‌

US Patent 10676710 Cell culture compositions with antioxidants and methods for polypeptide production

‌

US Patent 6900056 Chemically defined medium for cultured mammalian cells

‌

US Patent 7070959 Modified chimeric polypeptides with improved pharmacokinetic properties

‌

US Patent 7332303 Product quality enhancement in mammalian cell culture processes for protein production

‌

US Patent 8198084 Serum-free mammalian cell culture medium, and uses thereof

...

Patent Primary Examiner

CPC Code

Patent abstract

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12012445 Anti-VEGF protein compositions and methods for producing the same

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12012445 Anti-VEGF protein compositions and methods for producing the same